<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=838528320191540&amp;ev=PageView&amp;noscript=1">
Donate

Latest Broadcast

From Poverty to Ph.D., Part 1

Guest: Dr. Carol Swain

Donate

May 01, 2023

Life Setback at Court

Pro-life advocates, including JDFI, are disappointed in the Supreme Court's 7-2 decision to preserve, for now, continued access to the abortion pill mifepristone. Only Justices Clarence Thomas and Samuel Alito dissented from the decision.

The Supreme Court was considering the issue because on April 7 two separate U.S. district courts issued contradictory opinions. U.S. District Judge Matthew Kacsmaryk, in Amarillo, Texas, ordered the suspension of the Food and Drug Administration's (FDA) approval of the drug. Judge Kacsmaryk said the FDA had not sufficiently examined the drug's long-term health impact on women. U.S. District Judge Thomas Rice, based in Spokane, Washington, ruled that the pill must remain available in the 15 states and the District of Columbia that sued to protect access to the abortion pill.

When the Biden administration appealed Judge Kacsmaryk's decision, a three-judge panel of the Fifth Circuit Court of Appeals blocked his decision on the FDA's approval of the drug, while upholding the suspension of dispensing the drug by mail. At that point, the Biden administration appealed the case to the Supreme Court, leading to the disappointing 7-2 ruling.

Of course, this is the same Supreme Court that boldly, in June of 2022, finally ended the complete legal fiction that there was a constitutional right to abortion "hidden" in our founding document. That decision is already saving the lives of thousands of unborn children. It also resulted in the Biden administration "doubling down" on promoting more abortion. The administration even established a special intra-agency working group to prevent the decline of the number of abortions in America.

For now, the Supreme Court has eliminated the restrictions on the abortion-inducing drug until the controversy over whether the FDA followed the correct procedures works its way through the judiciary.

Our friends at the Alliance Defending Freedom, which is leading the legal charge against the FDA's approval of the abortion pill, said Friday that the Supreme Court was maintaining "the status quo that existed prior to our lawsuit while our challenge . . . moves forward."

Related Articles

  See More Articles

January 22, 2025

A New Day Dawns in Washington

On the first day of the Trump-Vance administration, President Trump issued hundreds of executive orders. One asserted that there are only two sexes, male and female. In doing so, the president was merely repeating what the Bible tells us in Genesis 1:27: “So God created man in his own image, in the image of God he created him; male and female he created them” (ESV).

January 15, 2025

Title IX’s Original Protection for Girls and Women

Here’s what happened. The dispute has involved Title IX of the Higher Education Amendments of 1972. That law was intended to protect women and girls from discrimination in education. Experts have said the law has been incredibly effective for over fifty years in expanding opportunities for females.

December 18, 2024

Happy Christmas!

A significant exchange of words occurred a few days ago between First Lady Jill Biden and a young American child. Children were at the White House on the occasion of the Marine Corps Reserve’s Toys for Tots campaign. Mrs. Biden greeted the children with a shout of “Happy Holidays!” One courageous child loudly responded, “Happy Christmas!”